AURELIA ONLINE / 7.5mgで痩せない理由
Why Am I Not Losing Weight on Mounjaro 7.5 mg?
Common reasons weight may not decrease after increasing to Mounjaro 7.5 mg, including timing, constipation, fluid retention, calorie intake, sleep, activity, and injection handling.
Key points
- Four weeks is the minimum interval before another increase, not the time required to see the full long-term effect. Evaluate trends rather than a single weekly measurement.
It may be too early
- Four weeks is the minimum interval before another increase, not the time required to see the full long-term effect. Evaluate trends rather than a single weekly measurement.
Common hidden causes
- Constipation and fluid retention can mask fat loss.
- Liquid calories, alcohol, frequent snacks, and larger portions may continue despite reduced appetite.
- Lower activity, sleep deprivation, stress, or muscle loss can reduce total energy expenditure.
What to check before increasing again
- Review injection technique and storage.
- Measure waist circumference and weekly weight under the same conditions.
- Review adverse effects, food intake, hydration, bowel movements, and glucose control with a clinician.
Frequently asked questions
It may be too early?
Four weeks is the minimum interval before another increase, not the time required to see the full long-term effect. Evaluate trends rather than a single weekly measurement.
Common hidden causes?
Constipation and fluid retention can mask fat loss. Liquid calories, alcohol, frequent snacks, and larger portions may continue despite reduced appetite. Lower activity, sleep deprivation, stress, or muscle loss can reduce total energy expenditure.
What to check before increasing again?
Review injection technique and storage. Measure waist circumference and weekly weight under the same conditions. Review adverse effects, food intake, hydration, bowel movements, and glucose control with a clinician.
References
Related pages
Book an online consultationThis page provides general medical information and does not replace individual diagnosis or treatment. In Japan, Mounjaro is approved for type 2 diabetes; use for weight management is off-label. Dose changes must be decided after medical review.